Clinical factors associated with early progression and grade 3–4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab

Coraline Dumenil; Marie-Ange Massiani; Jennifer Dumoulin; Violaine Giraud; Sylvie Labrune; Thierry Chinet; Etienne Giroux Leprieur

doi:10.1371/journal.pone.0195945

Loading metrics

Open Access

Peer-reviewed

Research Article

Clinical factors associated with early progression and grade 3–4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab

Coraline Dumenil,

Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

Affiliation Department of Respiratory Diseases and Thoracic Oncology, APHP—Ambroise Pare Hospital, Boulogne-Billancourt, France
⨯
Marie-Ange Massiani,

Roles Data curation, Writing – review & editing

Affiliation Department of Medical Oncology, René Huguenin Hospital, Curie Institute, Saint-Cloud, France
⨯
Jennifer Dumoulin,

Roles Writing – review & editing

Affiliation Department of Respiratory Diseases and Thoracic Oncology, APHP—Ambroise Pare Hospital, Boulogne-Billancourt, France
⨯
Violaine Giraud,

Roles Writing – review & editing

Affiliation Department of Respiratory Diseases and Thoracic Oncology, APHP—Ambroise Pare Hospital, Boulogne-Billancourt, France
⨯
Sylvie Labrune,

Roles Writing – review & editing

Affiliation Department of Respiratory Diseases and Thoracic Oncology, APHP—Ambroise Pare Hospital, Boulogne-Billancourt, France
⨯
Thierry Chinet,

Roles Supervision, Validation, Writing – review & editing

Affiliations Department of Respiratory Diseases and Thoracic Oncology, APHP—Ambroise Pare Hospital, Boulogne-Billancourt, France, EA4340, University of Versailles Saint-Quentin-en-Yvelines, Paris-Saclay University, Boulogne-Billancourt, France
⨯
Etienne Giroux Leprieur

Roles Conceptualization, Formal analysis, Methodology, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

* E-mail: etienne.giroux-leprieur@aphp.fr

Affiliations Department of Respiratory Diseases and Thoracic Oncology, APHP—Ambroise Pare Hospital, Boulogne-Billancourt, France, EA4340, University of Versailles Saint-Quentin-en-Yvelines, Paris-Saclay University, Boulogne-Billancourt, France

http://orcid.org/0000-0001-8441-1701

⨯

Clinical factors associated with early progression and grade 3–4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab

Coraline Dumenil,
Marie-Ange Massiani,
Jennifer Dumoulin,
Violaine Giraud,
Sylvie Labrune,
Thierry Chinet,
Etienne Giroux Leprieur

Published: April 23, 2018
https://doi.org/10.1371/journal.pone.0195945

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Central nervous system
Is the Subject Area "Central nervous system" applicable to this article?

Thanks for your feedback.
Brain metastasis
Is the Subject Area "Brain metastasis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Multivariate analysis
Is the Subject Area "Multivariate analysis" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Histology
Is the Subject Area "Histology" applicable to this article?

Thanks for your feedback.